FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Genell Knatterud

Research Profile

Disorders

Chemicals & Drugs

Tissue Plasminogen Activator

Procedures

Concepts & Ideas

Co-author Network

Publications

TOP 3
Harvey D White; Warren Cantor; Antonio C Carvalho; Vladimír Džavík; Genell L Knatterud; Mariusz Kruk; Gervasio A Lamas; Li Liu; C Edwin Martin; Venu Menon; Camille A Pearte; Harmony R Reynolds; Philippe Gabriel STEG; Judith S Hochman
Reinfarction after percutaneous coronary intervention or medical management using the universal definition in patients with total occlusion after myocardial infarction: results from long-term follow-up of the Occluded Artery Trial (OAT) cohort.
Michael J Domanski; Xin Tian; Jerome L Fleg; Sean Coady; Christine Gosen; Ruth Kirby; Vandana Sachdev; Genell L Knatterud; Eugene Braunwald
Pleiotropic effect of lovastatin, with and without cholestyramine, in the post coronary artery bypass graft (Post CABG) trial.
Bonnie Spring; Sherry Pagoto; Genell L Knatterud; Andrea Kozak; Donald Hedeker
Examination of the analytic quality of behavioral health randomized clinical trials.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Genell Knatterud (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: Harvey D White; Warren Cantor; Antonio C Carvalho; Vladimír Džavík; Genell L Knatterud; Mariusz Kruk; Gervasio A Lamas; Li Liu; C Edwin Martin; Venu Menon; Camille A Pearte; Harmony R Reynolds; Philippe Gabriel STEG; Judith S Hochman
Reinfarction after percutaneous coronary intervention or medical management using the universal definition in patients with total occlusion after myocardial infarction: results from long-term follow-up of the Occluded Artery Trial (OAT) cohort.
American heart journal 2012;163(4):563-71.
2008: Michael J Domanski; Xin Tian; Jerome L Fleg; Sean Coady; Christine Gosen; Ruth Kirby; Vandana Sachdev; Genell L Knatterud; Eugene Braunwald
Pleiotropic effect of lovastatin, with and without cholestyramine, in the post coronary artery bypass graft (Post CABG) trial.
The American journal of cardiology 2008;102(8):1023-7.
2007: Bonnie Spring; Sherry Pagoto; Genell L Knatterud; Andrea Kozak; Donald Hedeker
Examination of the analytic quality of behavioral health randomized clinical trials.
Journal of clinical psychology 2007;63(1):53-71.
2006: Judith S Hochman; Gervasio A Lamas; Christopher E Buller; Vladimir Dzavik; Harmony R Reynolds; Staci J Abramsky; Sandra Forman; Witold Ruzyllo; Aldo P Maggioni; Harvey White; Zygmunt Sadowski; Antonio C Carvalho; Jamie M Rankin; Jean P Renkin; Philippe Gabriel STEG; Alice M Mascette; George Sopko; Matthias E Pfisterer; Jonathan Leor; Viliam Fridrich; Daniel B Mark; Genell L Knatterud
Coronary intervention for persistent occlusion after myocardial infarction.
The New England journal of medicine 2006;355(23):2395-407.
2006: Vladimír Dzavík; Christopher E Buller; Gervasio A Lamas; James M Rankin; G B John Mancini; Warren J Cantor; Ronald J Carere; John R Ross; Deborah Atchison; Sandra Forman; Boban Thomas; Pawel Buszman; Carlos Vozzi; Anthony Glanz; Eric A Cohen; Peter Meciar; Gerald Devlin; Alice Mascette; George Sopko; Genell L Knatterud; Judith S Hochman
Randomized trial of percutaneous coronary intervention for subacute infarct-related coronary artery occlusion to achieve long-term patency and improve ventricular function: the Total Occlusion Study of Canada (TOSCA)-2 trial.
Circulation 2006;114(23):2449-57.
2006: Robert P Baughman; Marc A Judson; Alvin S Teirstein; Henry Yeager; Milton D Rossman; Genell L Knatterud; Bruce Thompson
Presenting characteristics as predictors of duration of treatment in sarcoidosis.
QJM : monthly journal of the Association of Physicians 2006;99(5):307-15.
2005: Judith S Hochman; Gervasio A Lamas; Genell L Knatterud; Christopher E Buller; Vladimir Dzavik; Daniel B Mark; Harmony R Reynolds; Harvey D White
Design and methodology of the Occluded Artery Trial (OAT).
American heart journal 2005;150(4):627-42.
2005: Lucien Campeau; Jacques Lespérance; Luc Bilodeau; Annik Fortier; Marie-Claude Guertin; Genell L Knatterud
Effect of cholesterol lowering and cardiovascular risk factors on the progression of aortoiliac arteriosclerosis: a quantitative cineangiography study.
Angiology 2005;56(2):191-9.
2005: Juliana Barnard; Cecile Rose; Lee Newman; Martha Canner; John W Martyny; Charles McCammon; Eddy A Bresnitz; Milton D Rossman; Bruce Thompson; Benjamin A Rybicki; Steven E Weinberger; David R Moller; Geoffrey McLennan; Gary W Hunninghake; Louis DePalo; Robert P Baughman; Michael C Iannuzzi; Marc A Judson; Genell L Knatterud; Alvin S Teirstein; Henry Yeager; Carol J Johns; David L Rabin; Reuben M Cherniack
Job and industry classifications associated with sarcoidosis in A Case-Control Etiologic Study of Sarcoidosis (ACCESS).
Journal of occupational and environmental medicine / American College of Occupational and Environmental Medicine 2005;47(3):226-34.
2005: Michael Cusick; Annal D Meleth; Elvira Agrón; Marion R Fisher; George F Reed; Genell L Knatterud; Franca Barton; Matthew D Davis; Frederick L Ferris; Emily Y Chew
Associations of mortality and diabetes complications in patients with type 1 and type 2 diabetes: early treatment diabetic retinopathy study report no. 27.
Diabetes care 2005;28(3):617-25.
2004: Lee Newman; Cecile S Rose; Eddy A Bresnitz; Milton D Rossman; Juliana Barnard; Margaret Frederick; Michael L Terrin; Steven E Weinberger; David R Moller; Geoffrey McLennan; Gary W Hunninghake; Louis DePalo; Robert P Baughman; Michael C Iannuzzi; Marc A Judson; Genell L Knatterud; Bruce W Thompson; Alvin S Teirstein; Henry Yeager; Carol J Johns; David L Rabin; Benjamin A Rybicki; Reuben M Cherniack
A case control etiologic study of sarcoidosis: environmental and occupational risk factors.
American journal of respiratory and critical care medicine 2004;170(12):1324-30.
2004: Kent D Taylor; Maren T Scheuner; Huiying Yang; Yaping Wang; Talin Haritunians; Nathan Fischel-Ghodsian; Prediman K Shah; James S Forrester; Genell L Knatterud; Jerome I Rotter
Lipoprotein lipase locus and progression of atherosclerosis in coronary-artery bypass grafts.
Genetics in medicine : official journal of the American College of Medical Genetics 2004;6(6):481-6.
2004: Charles H Hennekens; Genell L Knatterud; Marc A Pfeffer
Use of aspirin to reduce risks of cardiovascular disease in patients with diabetes: clinical and research challenges.
Diabetes care 2004;27(11):2752-4.
2004: Franca Barton; Donald S Fong; Genell L Knatterud
Classification of Farnsworth-Munsell 100-hue test results in the early treatment diabetic retinopathy study.
American journal of ophthalmology 2004;138(1):119-24.
2003: Ruth Lindquist; Gilles Dupuis; Michael L Terrin; Byron J Hoogwerf; Susan M Czajkowski; J Alan Herd; Franca Barton; Mary Fran Tracy; Donald B Hunninghake; Diane Treat-Jacobson; Sally Shumaker; Steve Zyzanski; Irvin Goldenberg; Genell L Knatterud
Comparison of health-related quality-of-life outcomes of men and women after coronary artery bypass surgery through 1 year: findings from the POST CABG Biobehavioral Study.
American heart journal 2003;146(6):1038-44.
2003: Karina W Davidson; Michael Goldstein; Robert M Kaplan; Peter G Kaufmann; Genell L Knatterud; C Tracy Orleans; Bonnie Spring; Kimberlee J Trudeau; Evelyn P. Whitlock
Evidence-based behavioral medicine: what is it and how do we achieve it?
Annals of behavioral medicine : a publication of the Society of Behavioral Medicine 2003;26(3):161-71.
2003: Marc A Judson; Robert P Baughman; Bruce W Thompson; Alvin S Teirstein; Michael L Terrin; Milton D Rossman; Henry Yeager; Geoffrey McLennan; Eddy A Bresnitz; Louis DePalo; Gary W Hunninghake; Michael C Iannuzzi; Carol J Johns; David R Moller; Lee Newman; David L Rabin; Cecile Rose; Benjamin A Rybicki; Steven E Weinberger; Genell L Knatterud; Reuben Cherniak
Two year prognosis of sarcoidosis: the ACCESS experience.
Sarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG / World Association of Sarcoidosis and Other Granulomatous Disorders 2003;20(3):204-11.
2003: Genell L Knatterud; Carl White; Nancy Geller; Lucien Campeau; Sandra A Forman; Michael J Domanski; James S Forrester; Fredarick L Gobel; J Alan Herd; Ann Hickey; Byron J Hoogwerf; Donald B Hunninghake; Michael L Terrin; Yves Rosenberg
Angiographic changes in saphenous vein grafts are predictors of clinical outcomes.
American heart journal 2003;145(2):262-9.
2002: THOMAS AVERSANO; Lynnet T Aversano; Eugene Passamani; Genell L Knatterud; Michael L Terrin; David O Williams; Sandra A Forman
Thrombolytic therapy vs primary percutaneous coronary intervention for myocardial infarction in patients presenting to hospitals without on-site cardiac surgery: a randomized controlled trial.
JAMA : the journal of the American Medical Association 2002;287(15):1943-51.
2002: David S Sheps; Robert P McMahon; Lewis C Becker; Robert M Carney; Kenneth E Freedland; Jerome D Cohen; David Sheffield; Alan David Goldberg; Mark William Ketterer; Carl J Pepine; James M Raczynski; Kathleen C Light; David S Krantz; Peter H Stone; Genell L Knatterud; Peter G Kaufmann
Mental stress-induced ischemia and all-cause mortality in patients with coronary artery disease: Results from the Psychophysiological Investigations of Myocardial Ischemia study.
Circulation 2002;105(15):1780-4.
2002: Genell L Knatterud
Management and conduct of randomized controlled trials.
Epidemiologic reviews 2002;24(1):12-25.
2001: Benjamin A Rybicki; Michael C Iannuzzi; Margaret Frederick; Bruce W Thompson; Milton D Rossman; Eddy A Bresnitz; Michael L Terrin; David R Moller; Juliana Barnard; Robert P Baughman; Louis DePalo; Gary W Hunninghake; Carol J Johns; Marc A Judson; Genell L Knatterud; Geoffrey McLennan; Lee Newman; David L Rabin; C Rose; Alvin S Teirstein; Steven E Weinberger; Henry Yeager; Reuben M Cherniack
Familial aggregation of sarcoidosis. A case-control etiologic study of sarcoidosis (ACCESS).
American journal of respiratory and critical care medicine 2001;164(11):2085-91.
2001: CW White; Fredarick L Gobel; Lucien Campeau; Genell L Knatterud; Sandra A Forman; James S Forrester; Nancy Geller; J Alan Herd; Ann Hickey; Byron J Hoogwerf; Donald B Hunninghake; Yves Rosenberg; Michael L Terrin
Effect of an aggressive lipid-lowering strategy on progression of atherosclerosis in the left main coronary artery from patients in the post coronary artery bypass graft trial.
Circulation 2001;104(22):2660-5.
2001: Robert P Baughman; Alvin S Teirstein; Marc A Judson; Milton D Rossman; Henry Yeager; Eddy A Bresnitz; Louis DePalo; Gary W Hunninghake; Michael C Iannuzzi; Carol J Johns; Geoffrey McLennan; David R Moller; Lee Newman; David L Rabin; C Rose; Benjamin A Rybicki; Steven E Weinberger; Michael L Terrin; Genell L Knatterud; R Cherniak
Clinical characteristics of patients in a case control study of sarcoidosis.
American journal of respiratory and critical care medicine 2001;164(10 Pt 1):1885-9.
2001: CW White; Lucien Campeau; Paul L Canner; Michael J Domanski; James S Forrester; Fredarick L Gobel; J Alan Herd; Byron J Hoogwerf; Donald B Hunninghake; Genell L Knatterud; F LoPresti
Lessons from the post coronary artery bypass graft study in evaluating and controlling technical variability in angiographic trials. Post CABG Investigators.
The American journal of cardiology 2001;87(1):40-3.
2000: Michael J Domanski; C B Borkowf; Lucien Campeau; Genell L Knatterud; C White; Byron J Hoogwerf; Yves Rosenberg; Nancy Geller
Prognostic factors for atherosclerosis progression in saphenous vein grafts: the postcoronary artery bypass graft (Post-CABG) trial. Post-CABG Trial Investigators.
Journal of the American College of Cardiology 2000;36(6):1877-83.
2000: Genell L Knatterud; Yves Rosenberg; Lucien Campeau; Nancy Geller; Donald B Hunninghake; Sandra A Forman; James S Forrester; Fredarick L Gobel; J Alan Herd; Ann Hickey; Byron J Hoogwerf; Michael L Terrin; C White
Long-term effects on clinical outcomes of aggressive lowering of low-density lipoprotein cholesterol levels and low-dose anticoagulation in the post coronary artery bypass graft trial. Post CABG Investigators.
Circulation 2000;102(2):157-65.
2000: N K Wenger; Genell L Knatterud; Paul L Canner
Early risks of hormone therapy in patients with coronary heart disease.
JAMA : the journal of the American Medical Association 2000;284(1):41-3.
1999: Carl J Pepine; D B Mark; Martial G Bourassa; Bernard R Chaitman; Richard F Davies; Genell L Knatterud; Sandra Forman; Craig M Pratt; George Sopko; C Richard Conti
Cost estimates for treatment of cardiac ischemia (from the Asymptomatic Cardiac Ischemia Pilot [ACIP] study).
The American journal of cardiology 1999;84(11):1311-6.
1999: Peter H Stone; B Thompson; B L Zaret; Bernard R Chaitman; R S Gibson; M J Schweiger; Richard M Steingart; James M Kirshenbaum; C Thompson; A Fung; Carolyn H McCabe; Genell L Knatterud; Eugene Braunwald
Factors associated with failure of medical therapy in patients with unstable angina and non-Q wave myocardial infarction. A TIMI-IIIB database study.
European heart journal 1999;20(15):1084-93.
1999: Lucien Campeau; Donald B Hunninghake; Genell L Knatterud; CW White; Michael J Domanski; Sandra A Forman; James S Forrester; Nancy Geller; Fredarick L Gobel; J Alan Herd; Byron J Hoogwerf; Yves Rosenberg
Aggressive cholesterol lowering delays saphenous vein graft atherosclerosis in women, the elderly, and patients with associated risk factors. NHLBI post coronary artery bypass graft clinical trial. Post CABG Trial Investigators.
Circulation 1999;99(25):3241-7.
1999: Carl J Pepine; Martial G Bourassa; Bernard R Chaitman; Richard F Davies; Richard A Kerensky; Barry L Sharaf; Genell L Knatterud; Sandra A Forman; Craig M Pratt; Edward D Staples; George Sopko; C Richard Conti
Factors influencing clinical outcomes after revascularization in the asymptomatic cardiac ischemia pilot (ACIP). ACIP Study Group.
Journal of cardiac surgery 1999;14(1):1-8.
1998: Genell L Knatterud; F W Rockhold; S L George; Franca Barton; Clarence E Davis; W R Fairweather; T Honohan; R Mowery; R O'Neill
Guidelines for quality assurance in multicenter trials: a position paper.
Controlled clinical trials 1998;19(5):477-93.
1998: David S Sheps; Robert P McMahon; Carl J Pepine; Peter H Stone; Alan David Goldberg; H Taylor; Jerome D Cohen; Lewis C Becker; Bernard R Chaitman; Genell L Knatterud; Peter G Kaufmann
Heterogeneity among cardiac ischemic and anginal responses to exercise, mental stress, and daily life.
The American journal of cardiology 1998;82(1):1-6.
1998: M D Davis; M R Fisher; Ronald E Gangnon; Franca Barton; L M Aiello; Emily Y Chew; Frederick L Ferris; Genell L Knatterud
Risk factors for high-risk proliferative diabetic retinopathy and severe visual loss: Early Treatment Diabetic Retinopathy Study Report #18.
Investigative ophthalmology & visual science 1998;39(2):233-52.
1998: Robert M Carney; Robert P McMahon; Kenneth E Freedland; Lewis C Becker; D S Krantz; Michael A Proschan; James M Raczynski; Mark William Ketterer; Genell L Knatterud; Kathleen C Light; L Lindholm; David S Sheps
Reproducibility of mental stress-induced myocardial ischemia in the Psychophysiological Investigations of Myocardial Ischemia (PIMI).
Psychosomatic medicine 1998;60(1):64-70.
1998: Peter G Kaufmann; Robert P McMahon; Lewis C Becker; B Bertolet; R Bonsall; B Chaitman; J D Cohen; S Forman; Alan David Goldberg; Kenneth E Freedland; Mark William Ketterer; D S Krantz; Carl J Pepine; James M Raczynski; Peter H Stone; H Taylor; Genell L Knatterud; David S Sheps
The Psychophysiological Investigations of Myocardial Ischemia (PIMI) study: objective, methods, and variability of measures.
Psychosomatic medicine 1998;60(1):56-63.
1997: Peter H Stone; Bernard R Chaitman; Sandra Forman; Thomas C Andrews; V Bittner; Martial G Bourassa; Richard F Davies; J E Deanfield; W Frishman; Alan David Goldberg; Gail MacCallum; Pamela Ouyang; Carl J Pepine; Craig M Pratt; B Sharaf; Richard M Steingart; Genell L Knatterud; George Sopko; C Richard Conti
Prognostic significance of myocardial ischemia detected by ambulatory electrocardiography, exercise treadmill testing, and electrocardiogram at rest to predict cardiac events by one year (the Asymptomatic Cardiac Ischemia Pilot [ACIP] study)
The American journal of cardiology 1997;80(11):1395-401.
1997: Lucien Campeau; Genell L Knatterud; B Hunninghake; Michael J Domanski
Optimizing cholesterol lowering therapy: contribution of the Post Coronary Artery Bypass Graft Trial.
European heart journal 1997;18(11):1683-5.
1997: Paul L Canner; B Thompson; Genell L Knatterud; Nancy Geller; Lucien Campeau; D Zucker
An application of the Zucker-Wittes modified ratio estimate statistic in the Post Coronary Artery Bypass Graft (CABG) clinical trial.
Controlled clinical trials 1997;18(4):318-27.
1997: Judith S Hochman; Carolyn H McCabe; Peter H Stone; R C Becker; C P Cannon; T DeFeo-Fraulini; B Thompson; Richard M Steingart; Genell L Knatterud; E Braunwald
Outcome and profile of women and men presenting with acute coronary syndromes: a report from TIMI IIIB. TIMI Investigators. Thrombolysis in Myocardial Infarction.
Journal of the American College of Cardiology 1997;30(1):141-8.
1997: Michael A Sloan; Thomas R Price; Michael L Terrin; Sandra Forman; Joel M Gore; B R Chaitman; M Hodges; H Mueller; William J Rogers; Genell L Knatterud; E Braunwald
Ischemic cerebral infarction after rt-PA and heparin therapy for acute myocardial infarction. The TIMI-II pilot and randomized clinical trial combined experience.
Stroke; a journal of cerebral circulation 1997;28(6):1107-14.
1997: Carl J Pepine; Barry L Sharaf; Thomas C Andrews; Sandra Forman; Nancy Geller; Genell L Knatterud; John J Mahmarian; Pamela Ouyang; William J Rogers; George Sopko; Richard M Steingart; Peter H Stone; C Richard Conti
Relation between clinical, angiographic and ischemic findings at baseline and ischemia-related adverse outcomes at 1 year in the Asymptomatic Cardiac Ischemia Pilot study. ACIP Study Group.
Journal of the American College of Cardiology 1997;29(7):1483-9.
1997: Richard F Davies; Alan David Goldberg; Sandra Forman; Carl J Pepine; Genell L Knatterud; Nancy Geller; George Sopko; C Pratt; J Deanfield; C Richard Conti
Asymptomatic Cardiac Ischemia Pilot (ACIP) study two-year follow-up: outcomes of patients randomized to initial strategies of medical therapy versus revascularization.
Circulation 1997;95(8):2037-43.
1997: Susan M Czajkowski; Michael L Terrin; Ruth Lindquist; Byron J Hoogwerf; G Dupuis; S A Shumaker; J R Gray; J Alan Herd; Diane Treat-Jacobson; S Zyzanski; Genell L Knatterud
Comparison of preoperative characteristics of men and women undergoing coronary artery bypass grafting (the Post Coronary Artery Bypass Graft [CABG] Biobehavioral Study).
The American journal of cardiology 1997;79(8):1017-24.
1997: C Richard Conti; Nancy Geller; Genell L Knatterud; Sandra A Forman; Craig M Pratt; Carl J Pepine; George Sopko
Anginal status and prediction of cardiac events in patients enrolled in the asymptomatic cardiac ischemia pilot (ACIP) study. ACIP investigators.
The American journal of cardiology 1997;79(7):889-92.
1997: E G Bovill; Russell P Tracy; Genell L Knatterud; Peter H Stone; J Nasmith; Joel M Gore; Bruce W Thompson; G H Tofler; N S Kleiman; C Cannon; Eugene Braunwald
Hemorrhagic events during therapy with recombinant tissue plasminogen activator, heparin, and aspirin for unstable angina (Thrombolysis in Myocardial Ischemia, phase IIIB trial).
The American journal of cardiology 1997;79(4):391-6.
1996: Genell L Knatterud; S W Greenhouse
Tributes to Dr. Thomas C. Chalmers.
Controlled clinical trials 1996;17(6):473-5.
1996: Lewis C Becker; C J Pepine; R Bonsall; J D Cohen; Alan David Goldberg; C Coghlan; Peter H Stone; Sandra Forman; Genell L Knatterud; D S Sheps; Peter G Kaufmann
Left ventricular, peripheral vascular, and neurohumoral responses to mental stress in normal middle-aged men and women. Reference Group for the Psychophysiological Investigations of Myocardial Ischemia (PIMI) Study.
Circulation 1996;94(11):2768-77.
1996: David O Williams; Eugene Braunwald; B Thompson; Barry L Sharaf; C E Buller; Genell L Knatterud
Results of percutaneous transluminal coronary angioplasty in unstable angina and non-Q-wave myocardial infarction. Observations from the TIMI IIIB Trial.
Circulation 1996;94(11):2749-55.
1996: Richard C Becker; Christopher P Cannon; E G Bovill; R P Tracy; B Thompson; Genell L Knatterud; A Randall; B Braunwald
Prognostic value of plasma fibrinogen concentration in patients with unstable angina and non-Q-wave myocardial infarction (TIMI IIIB Trial)
The American journal of cardiology 1996;78(2):142-7.
1996: Craig M Pratt; Robert P McMahon; Sidney Goldstein; Carl J Pepine; Thomas C Andrews; I Dyrda; W H Frishman; N L Geller; J A Hill; N A Morgan; Peter H Stone; Genell L Knatterud; George Sopko; C Richard Conti
Comparison of subgroups assigned to medical regimens used to suppress cardiac ischemia (the Asymptomatic Cardiac Ischemia Pilot [ACIP] Study).
The American journal of cardiology 1996;77(15):1302-9.
1996: Peter H Stone; B Thompson; H V Anderson; M W Kronenberg; R S Gibson; William J Rogers; DJ Diver; P Théroux; J W Warnica; J B Nasmith; C Kells; N Kleiman; Carolyn H McCabe; M Schactman; Genell L Knatterud; Eugene Braunwald
Influence of race, sex, and age on management of unstable angina and non-Q-wave myocardial infarction: The TIMI III registry.
JAMA : the journal of the American Medical Association 1996;275(14):1104-12.
1995: Martial G Bourassa; Genell L Knatterud; Carl J Pepine; George Sopko; William J Rogers; N L Geller; I Dyrda; Sandra A Forman; Bernard R Chaitman; Barry L Sharaf
Asymptomatic Cardiac Ischemia Pilot (ACIP) Study. Improvement of cardiac ischemia at 1 year after PTCA and CABG.
Circulation 1995;92(9 Suppl):II1-7.
1995: H S Mueller; Sandra A Forman; Mark Menegus; L S Cohen; Genell L Knatterud; Eugene Braunwald
Prognostic significance of nonfatal reinfarction during 3-year follow-up: results of the Thrombolysis in Myocardial Infarction (TIMI) phase II clinical trial. The TIMI Investigators.
Journal of the American College of Cardiology 1995;26(4):900-7.
1995: Barry L Zaret; Frans J Th Wackers; Michael L Terrin; Sandra A Forman; David O Williams; Genell L Knatterud; Eugene Braunwald
Value of radionuclide rest and exercise left ventricular ejection fraction in assessing survival of patients after thrombolytic therapy for acute myocardial infarction: results of Thrombolysis in Myocardial Infarction (TIMI) phase II study. The TIMI Study Group.
Journal of the American College of Cardiology 1995;26(1):73-9.
1995: Genell L Knatterud; C Meinart
A tribute to Christian Robert Klimt (1918-1994).
Controlled clinical trials 1995;16(3):139-42.
1995: Bernard J Gersh; J H Chesebro; Eugene Braunwald; Costas T Lambrew; E Passamani; R E Solomon; A M Ross; R Ross; Michael L Terrin; Genell L Knatterud
Coronary artery bypass graft surgery after thrombolytic therapy in the Thrombolysis in Myocardial Infarction Trial, Phase II (TIMI II).
Journal of the American College of Cardiology 1995;25(2):395-402.
1995: C Richard Conti; Martial G Bourassa; Bernard R Chaitman; N L Geller; Genell L Knatterud; Carl J Pepine; C Pratt; George Sopko
Asymptomatic cardiac ischemia pilot (ACIP).
Transactions of the American Clinical and Climatological Association 1995;106():77-83; discussion 83-4.
1994: M J Schweiger; Robert P McMahon; Michael L Terrin; N A Ruocco; M N Porway; A H Wiseman; Genell L Knatterud; E Braunwald
Comparison of patients with < 60% to > or = 60% diameter narrowing of the myocardial infarct-related artery after thrombolysis. The TIMI Investigators.
The American journal of cardiology 1994;74(2):105-10.
1994: Genell L Knatterud; Martial G Bourassa; Carl J Pepine; N L Geller; George Sopko; Bernard R Chaitman; C Pratt; Peter H Stone; Richard F Davies; William J Rogers
Effects of treatment strategies to suppress ischemia in patients with coronary artery disease: 12-week results of the Asymptomatic Cardiac Ischemia Pilot (ACIP) study.
Journal of the American College of Cardiology 1994;24(1):11-20.
1994: Carl J Pepine; N L Geller; Genell L Knatterud; Martial G Bourassa; Bernard R Chaitman; Richard F Davies; P Day; J E Deanfield; Alan David Goldberg; Robert P McMahon
The Asymptomatic Cardiac Ischemia Pilot (ACIP) study: design of a randomized clinical trial, baseline data and implications for a long-term outcome trial.
Journal of the American College of Cardiology 1994;24(1):1-10.
1994: Richard C Becker; Michael L Terrin; R Ross; Genell L Knatterud; P Desvigne-Nickens; Joel M Gore; Eugene Braunwald
Comparison of clinical outcomes for women and men after acute myocardial infarction. The Thrombolysis in Myocardial Infarction Investigators.
Annals of internal medicine 1994;120(8):638-45.
1993: Michael L Terrin; David O Williams; N S Kleiman; J Willerson; H S Mueller; P Desvigne-Nickens; Sandra A Forman; Genell L Knatterud; Eugene Braunwald
Two- and three-year results of the Thrombolysis in Myocardial Infarction (TIMI) Phase II clinical trial.
Journal of the American College of Cardiology 1993;22(7):1763-72.
1993: B R Chaitman; Robert P McMahon; Michael L Terrin; L T Younis; Leslee J Shaw; D A Weiner; M M Frederick; Genell L Knatterud; George Sopko; E Braunwald
Impact of treatment strategy on predischarge exercise test in the Thrombolysis in Myocardial Infarction (TIMI) II Trial.
The American journal of cardiology 1993;71(2):131-8.
1992: G H Tofler; J E Muller; Peter H Stone; Sandra Forman; R E Solomon; Genell L Knatterud; Eugene Braunwald
Modifiers of timing and possible triggers of acute myocardial infarction in the Thrombolysis in Myocardial Infarction Phase II (TIMI II) Study Group.
Journal of the American College of Cardiology 1992;20(5):1049-55.
1992: N S Kleiman; Michael L Terrin; H Mueller; B Chaitman; R Roberts; Genell L Knatterud; R Solomon; Robert P McMahon; E Braunwald
Mechanisms of early death despite thrombolytic therapy: experience from the Thrombolysis in Myocardial Infarction Phase II (TIMI II) study.
Journal of the American College of Cardiology 1992;19(6):1129-35.
1992: E Braunwald; Genell L Knatterud; E Passamani
The rt-PA versus streptokinase. Controversy--II.
Journal of the American College of Cardiology 1992;19(5):1116-9.
1992: David O Williams; Eugene Braunwald; Genell L Knatterud; J Babb; J Bresnahan; Mark Greenberg; A Raizner; A Wasserman; T Robertson; R Ross
One-year results of the Thrombolysis in Myocardial Infarction investigation (TIMI) Phase II Trial.
Circulation 1992;85(2):533-42.
1992: B L Zaret; F J Wackers; Michael L Terrin; R Ross; M Weiss; J Slater; J Morrison; Robert Bourge; E Passamani; Genell L Knatterud
Assessment of global and regional left ventricular performance at rest and during exercise after thrombolytic therapy for acute myocardial infarction: results of the Thrombolysis in Myocardial Infarction (TIMI) II Study.
The American journal of cardiology 1992;69(1):1-9.
1991: Joel M Gore; Michael A Sloan; Thomas R Price; A M Randall; E Bovill; D Collen; Sandra Forman; Genell L Knatterud; George Sopko; Michael L Terrin
Intracerebral hemorrhage, cerebral infarction, and subdural hematoma after acute myocardial infarction and thrombolytic therapy in the Thrombolysis in Myocardial Infarction Study. Thrombolysis in Myocardial Infarction, Phase II, pilot and clinical trial.
Circulation 1991;83(2):448-59.
1991: R Roberts; William J Rogers; H S Mueller; Costas T Lambrew; DJ Diver; H C Smith; J T Willerson; Genell L Knatterud; Sandra Forman; E Passamani
Immediate versus deferred beta-blockade following thrombolytic therapy in patients with acute myocardial infarction. Results of the Thrombolysis in Myocardial Infarction (TIMI) II-B Study.
Circulation 1991;83(2):422-37.
1990: Frederick Feit; H S Mueller; Eugene Braunwald; R Ross; M Hodges; M V Herman; Genell L Knatterud
Thrombolysis in Myocardial Infarction (TIMI) phase II trial: outcome comparison of a "conservative strategy" in community versus tertiary hospitals. The TIMI Research Group.
Journal of the American College of Cardiology 1990;16(7):1529-34.
1990: Donald S Baim; Eugene Braunwald; Frederick Feit; Genell L Knatterud; E R Passamani; T L Robertson; William J Rogers; R E Solomon; David O Williams
The Thrombolysis in Myocardial Infarction (TIMI) Trial phase II: additional information and perspectives.
Journal of the American College of Cardiology 1990;15(5):1188-92.
1989: Genell L Knatterud
Thrombolysis in myocardial infarction (TIMI) randomized studies versus TIMI open label studies.
Controlled clinical trials 1989;10(4 Suppl):245S-256S.
1989: B R Chaitman; B Thompson; M D Wittry; D Stump; W P Hamilton; L D Hillis; J G Dwyer; R E Solomon; Genell L Knatterud
The use of tissue-type plasminogen activator for acute myocardial infarction in the elderly: results from thrombolysis in myocardial infarction Phase I, open label studies and the Thrombolysis in Myocardial Infarction Phase II pilot study. The TIMI Investigators.
Journal of the American College of Cardiology 1989;14(5):1159-65.
1989: Frans J Th Wackers; Michael L Terrin; D S Kayden; Genell L Knatterud; Sandra Forman; Eugene Braunwald; Barry L Zaret
Quantitative radionuclide assessment of regional ventricular function after thrombolytic therapy for acute myocardial infarction: results of phase I Thrombolysis in Myocardial Infarction (TIMI) trial.
Journal of the American College of Cardiology 1989;13(5):998-1005.
1988: J E Dalen; Joel M Gore; Eugene Braunwald; J Borer; R J Goldberg; E R Passamani; Sandra Forman; Genell L Knatterud
Six- and twelve-month follow-up of the phase I Thrombolysis in Myocardial Infarction (TIMI) trial.
The American journal of cardiology 1988;62(4):179-85.
1988: A K Rao; C Pratt; A Berke; A Jaffe; I Ockene; T L Schreiber; W R Bell; Genell L Knatterud; T L Robertson; Michael L Terrin
Thrombolysis in Myocardial Infarction (TIMI) Trial--phase I: hemorrhagic manifestations and changes in plasma fibrinogen and the fibrinolytic system in patients treated with recombinant tissue plasminogen activator and streptokinase.
Journal of the American College of Cardiology 1988;11(1):1-11.
1987: E Passamani; M Hodges; M Herman; R Grose; Bernard R Chaitman; W Rogers; Sandra Forman; Michael L Terrin; Genell L Knatterud; T Robertson
The Thrombolysis in Myocardial Infarction (TIMI) phase II pilot study: tissue plasminogen activator followed by percutaneous transluminal coronary angioplasty.
Journal of the American College of Cardiology 1987;10(5 Suppl B):51B-64B.
1987: Eugene Braunwald; Genell L Knatterud; E Passamani; T L Robertson; R Solomon
Update from the Thrombolysis in Myocardial Infarction Trial.
Journal of the American College of Cardiology 1987;10(4):970.
1987: J H Chesebro; Genell L Knatterud; R Roberts; J Borer; L S Cohen; J Dalen; H T Dodge; C K Francis; D Hillis; P Ludbrook
Thrombolysis in Myocardial Infarction (TIMI) Trial, Phase I: A comparison between intravenous tissue plasminogen activator and intravenous streptokinase. Clinical findings through hospital discharge.
Circulation 1987;76(1):142-54.
1987: Eugene Braunwald; Genell L Knatterud; E R Passamani; T L Robertson
Announcement of protocol change in thrombolysis in myocardial infarction trial.
Journal of the American College of Cardiology 1987;9(2):467.
1986: D O Williams; J Borer; E Braunwald; J H Chesebro; L S Cohen; J Dalen; H T Dodge; C K Francis; Genell L Knatterud; P Ludbrook
Intravenous recombinant tissue-type plasminogen activator in patients with acute myocardial infarction: a report from the NHLBI thrombolysis in myocardial infarction trial.
Circulation 1986;73(2):338-46.
1985: L D Hillis; J Borer; E Braunwald; J H Chesebro; L S Cohen; J Dalen; H T Dodge; C K Francis; Genell L Knatterud; P Ludbrook
High dose intravenous streptokinase for acute myocardial infarction: preliminary results of a multicenter trial.
Journal of the American College of Cardiology 1985;6(5):957-62.
1983: Genell L Knatterud; Sandra A Forman; P L Canner
The Coronary Drug Project. Design of data forms.
Controlled clinical trials 1983;4(4):429-40.